Peptide Laws in Canada
CA · Americas · 23 peptides tracked
Are Peptides Legal in Canada?
Canada regulates peptides as drugs under the Food and Drugs Act. Most research peptides are not scheduled under the Controlled Drugs and Substances Act (CDSA) but are considered unauthorized medicines by Health Canada. In 2026, Health Canada has taken the position that compounding GLP-1 agonists (particularly semaglutide) constitutes unauthorized manufacturing, as it involves unauthorized APIs and duplicates available authorized products. Enforcement against online peptide sales from foreign sources is increasing. Provincial regulations create regional variation — each province's college of pharmacists regulates compounding independently. HGH, semaglutide, tirzepatide, and liraglutide require prescriptions and have Drug Identification Numbers (DIN).
3
Legal10
Grey Area4
Prescription6
BannedCan You Buy Peptides in Canada?
3 peptide(s) are legal to buy in Canada, including NAD+, Glutathione, Vitamin B12. 4 peptide(s) require a valid prescription, including Tirzepatide, Semaglutide, HGH, Liraglutide. 10 peptide(s) fall into a legal grey area: Selank, MOTS-c, GHK-Cu, Semax, AOD-9604, and 5 more. These may be available for research purposes but their legality for personal use is ambiguous. 6 peptide(s) are banned: TB-500, Ipamorelin, CJC-1295, BPC-157, Retatrutide, and 1 more. Purchasing or possessing these is illegal.
Traveling to Canada with Peptides
When traveling to Canada with peptides, the legality depends on each peptide's classification. Do not bring banned substances (TB-500, Ipamorelin, CJC-1295, BPC-157, Retatrutide, and 1 more) — these could result in criminal penalties at customs. Prescription peptides (Tirzepatide, Semaglutide, HGH, Liraglutide) typically require documentation such as a prescription or doctor's letter when crossing borders. Enforcement in Canada is rated as "Strict." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Canada? Get verified wholesale quotes on peptide.broker →
Traveling to Canada with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Canada
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Prescription | Yes | Schedule F; DIN approved | — | Unsourced |
| Selank | Grey Area | No | Not Scheduled (CDSA) | Named in Health Canada seizure notice RA-77275 (April 2025). No DIN. Unauthorized drug but minimal active enforcement. | Official |
| MOTS-c | Grey Area | No | Not Scheduled (CDSA) | Not specifically named in enforcement actions. No DIN. Technically unauthorized if marketed for human use. | Official |
| TB-500 | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| GHK-Cu | Grey Area | No | Not Scheduled (CDSA) | Not specifically named in Health Canada enforcement actions. Topical skincare forms may be sold. Injectable form technically unauthorized. | Official |
| Ipamorelin | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| Semaglutide | Prescription | Yes | Schedule F; DIN approved | — | Unsourced |
| CJC-1295 | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| Semax | Grey Area | No | Not Scheduled (CDSA) | Same framework as Selank. Named in Health Canada seizures. No DIN. | Official |
| BPC-157 | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| NAD+ | Legal | No | Not Scheduled | NAD+ precursors (NMN/NR) sold as Natural Health Products with NPN numbers. IV infusions available at clinics. Not specifically restricted. | Official |
| Retatrutide | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| AOD-9604 | Grey Area | No | Not Scheduled (CDSA) | Named in Health Canada seizure notices. No DIN. Unauthorized drug. | Official |
| Glutathione | Legal | No | Supplement | Oral form: Regulated as Natural Health Product (NHP) with NPN. Injectable form: Would require DIN (drug) classification. | Unsourced |
| DSIP | Grey Area | No | Unauthorized Medicine | Unauthorized drug per Health Canada. Not scheduled under CDSA. Possession not criminal but sale/import for human use is illegal. | Official |
| Epithalon | Grey Area | No | Unauthorized Medicine | Unauthorized drug per Health Canada. Not CDSA-scheduled. | Unsourced |
| KPV | Grey Area | No | Unauthorized Medicine | Unauthorized drug per Health Canada. | Unsourced |
| HGH | Prescription | Yes | Schedule F; DIN approved | Health Canada approved. Multiple DINs. Not CDSA-listed. Prescription required. | Unsourced |
| Liraglutide | Prescription | Yes | Schedule F; DIN approved | Health Canada approved. Victoza and Saxenda have DINs. Not CDSA-scheduled. | Unsourced |
| Melanotan II | Grey Area | No | Unauthorized Medicine | Unauthorized drug per Health Canada. Specifically mentioned in seizure advisories. Adverse effects cited include melanoma, posterior reversible encephalopathy syndrome. | Official |
| MK-677 | Banned | No | Unauthorized Drug | Unauthorized drug. Health Canada issued a public advisory on 9 April 2026 naming BPC-157, CJC-1295, Ipamorelin, TB-500, GHK-Cu, MOTS-C, KPV, Epitalon, Melanotan I/II and Retatrutide, stating that unauthorized drug products are illegal in Canada and that products labelled "For Research Use Only - Not for Human Consumption" are NOT exempt from regulatory requirements. Selling without a DIN is prohibited (Food and Drug Regulations C.01.014). Not a controlled substance: nothing peptide-related appears in the CDSA schedules, which cover anabolic steroids but no peptides or GH secretagogues. Personal possession is not itself an offence; sale, advertising and commercial import are. Compounding is being enforced against: a Type I recall (RA-82047) covered BPC-157 and GHK-Cu supplied as unauthorized APIs to compounding pharmacies in May 2026. | Official |
| Vitamin B12 | Legal | No | Supplement | Oral: NHP with NPN (OTC). Injectable: Prescription drug (DIN). Covered by all provincial formularies. | Unsourced |
| PT-141 | Grey Area | No | Unauthorized Medicine | Not approved by Health Canada. No DIN. | Unsourced |
About the sources on this page
Entries marked Official cite a government regulator, legislation or an official gazette. Some entries currently carry no source at all.
We show these entries rather than hiding them, but they should not be relied on. Nothing on this site is legal advice. Verify against the national regulator before acting, and if you can point us at a better source please submit an update.
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.